Difference between revisions of "Risedronate (Actonel)"
m (Text replacement - "[[Media:" to "[[File:") |
Warner-admin (talk | contribs) m (Text replacement - "[http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or" to "or") |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
==General information== | ==General information== | ||
− | Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.actonel.com/global/prescribing_information.pdf Risedronate (Actonel) package insert]</ref><ref>[[File:Risedronate.pdf | Risedronate (Actonel) package insert (locally hosted backup)]]</ref><ref>[http://www.actonel.com/index.jsp Actonel manufacturer's website]</ref> | + | Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.actonel.com/global/prescribing_information.pdf Risedronate (Actonel) package insert]</ref><ref>[[:File:Risedronate.pdf | Risedronate (Actonel) package insert (locally hosted backup)]]</ref><ref>[http://www.actonel.com/index.jsp Actonel manufacturer's website]</ref> |
<br>Route: PO | <br>Route: PO | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
− | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, or the prescribing information.<ref name="insert"></ref> |
==Patient drug information== | ==Patient drug information== |
Latest revision as of 00:14, 6 July 2024
Also known as Actonel Einmal Woechentlich, Actonel O.A.W., Actonel one a week, Actonel Wekelijks, Actonel with Calcium, Atelvia, Benet, Ductonar, Gemfos, Maxidronato, NE 58095, Optinate, Optinate Septimum, Orafix, Osteonate, Osteorise, Ridron, Rised, Risedon, risedronic acid, risedronate sodium, Risendal, Risofos, Sedron, Seralis.
General information
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.[1][2][3]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, or the prescribing information.[1]
Patient drug information
- Patient counseling information can be found on page 33-39 of the Risedronate (Actonel) package insert[1]
- Risedronate (Actonel) patient drug information (UpToDate)[4]
Also known as
- Brand names: Actonel, Orafix, Ribone, Risedol, Risofos